Report Detail
Global Beta-Nicotinamide Mononucleotide (NMN) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
- RnM4530005 |
- 26 September, 2024 |
- Global |
- 86 Pages |
- GIR (Global Info Research) |
- Chemical & Material
Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.
According to our (Global Info Research) latest study, the global Beta-Nicotinamide Mononucleotide (NMN) market size was valued at US$ 371 million in 2023 and is forecast to a readjusted size of USD 774 million by 2030 with a CAGR of 10.6% during review period.
Core manufacturers of Nicotinamide Mononucleotide (NMN) include GeneHarbor, Mirarailab Bioscience, Maac10 Formulas, Herbalmax and Genex Formula. China is the largest production region, accounting for approximately 64% of the global market, followed by Japan and North America. In terms of product type, products with content ≥98% are the largest market segment, with a share of more than 99%. In terms of product application, the largest application market is health care products, with a share of approximately 99%.
This report is a detailed and comprehensive analysis for global Beta-Nicotinamide Mononucleotide (NMN) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Beta-Nicotinamide Mononucleotide (NMN) market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2019-2030
Global Beta-Nicotinamide Mononucleotide (NMN) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2019-2030
Global Beta-Nicotinamide Mononucleotide (NMN) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2019-2030
Global Beta-Nicotinamide Mononucleotide (NMN) market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Kg), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Beta-Nicotinamide Mononucleotide (NMN)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Beta-Nicotinamide Mononucleotide (NMN) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GeneHarbor, Herbalmax, Genex Formulas, Mirailab Bioscience, Maac10 Formulas, EffePharm, Bontac, CELFULL, Kingdomway, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Beta-Nicotinamide Mononucleotide (NMN) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Content ≥98%
Content ＜98%
Market segment by Application
Health Care Products
Cosmetics
Others
Major players covered
GeneHarbor
Herbalmax
Genex Formulas
Mirailab Bioscience
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Beta-Nicotinamide Mononucleotide (NMN) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Beta-Nicotinamide Mononucleotide (NMN), with price, sales quantity, revenue, and global market share of Beta-Nicotinamide Mononucleotide (NMN) from 2019 to 2024.
Chapter 3, the Beta-Nicotinamide Mononucleotide (NMN) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Beta-Nicotinamide Mononucleotide (NMN) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Beta-Nicotinamide Mononucleotide (NMN) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Beta-Nicotinamide Mononucleotide (NMN).
Chapter 14 and 15, to describe Beta-Nicotinamide Mononucleotide (NMN) sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Content ≥98%
- 1.3.3 Content ＜98%
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Health Care Products
- 1.4.3 Cosmetics
- 1.4.4 Others
- 1.5 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size & Forecast
- 1.5.1 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019 & 2023 & 2030)
- 1.5.2 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity (2019-2030)
- 1.5.3 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price (2019-2030)
2 Manufacturers Profiles
- 2.1 GeneHarbor
- 2.1.1 GeneHarbor Details
- 2.1.2 GeneHarbor Major Business
- 2.1.3 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Product and Services
- 2.1.4 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 GeneHarbor Recent Developments/Updates
- 2.2 Herbalmax
- 2.2.1 Herbalmax Details
- 2.2.2 Herbalmax Major Business
- 2.2.3 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Product and Services
- 2.2.4 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Herbalmax Recent Developments/Updates
- 2.3 Genex Formulas
- 2.3.1 Genex Formulas Details
- 2.3.2 Genex Formulas Major Business
- 2.3.3 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Product and Services
- 2.3.4 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Genex Formulas Recent Developments/Updates
- 2.4 Mirailab Bioscience
- 2.4.1 Mirailab Bioscience Details
- 2.4.2 Mirailab Bioscience Major Business
- 2.4.3 Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Product and Services
- 2.4.4 Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Mirailab Bioscience Recent Developments/Updates
- 2.5 Maac10 Formulas
- 2.5.1 Maac10 Formulas Details
- 2.5.2 Maac10 Formulas Major Business
- 2.5.3 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Product and Services
- 2.5.4 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Maac10 Formulas Recent Developments/Updates
- 2.6 EffePharm
- 2.6.1 EffePharm Details
- 2.6.2 EffePharm Major Business
- 2.6.3 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Product and Services
- 2.6.4 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 EffePharm Recent Developments/Updates
- 2.7 Bontac
- 2.7.1 Bontac Details
- 2.7.2 Bontac Major Business
- 2.7.3 Bontac Beta-Nicotinamide Mononucleotide (NMN) Product and Services
- 2.7.4 Bontac Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 Bontac Recent Developments/Updates
- 2.8 CELFULL
- 2.8.1 CELFULL Details
- 2.8.2 CELFULL Major Business
- 2.8.3 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Product and Services
- 2.8.4 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.8.5 CELFULL Recent Developments/Updates
- 2.9 Kingdomway
- 2.9.1 Kingdomway Details
- 2.9.2 Kingdomway Major Business
- 2.9.3 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Product and Services
- 2.9.4 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.9.5 Kingdomway Recent Developments/Updates
3 Competitive Environment: Beta-Nicotinamide Mononucleotide (NMN) by Manufacturer
- 3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Manufacturer (2019-2024)
- 3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturer (2019-2024)
- 3.3 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Manufacturer (2019-2024)
- 3.4 Market Share Analysis (2023)
- 3.4.1 Producer Shipments of Beta-Nicotinamide Mononucleotide (NMN) by Manufacturer Revenue ($MM) and Market Share (%): 2023
- 3.4.2 Top 3 Beta-Nicotinamide Mononucleotide (NMN) Manufacturer Market Share in 2023
- 3.4.3 Top 6 Beta-Nicotinamide Mononucleotide (NMN) Manufacturer Market Share in 2023
- 3.5 Beta-Nicotinamide Mononucleotide (NMN) Market: Overall Company Footprint Analysis
- 3.5.1 Beta-Nicotinamide Mononucleotide (NMN) Market: Region Footprint
- 3.5.2 Beta-Nicotinamide Mononucleotide (NMN) Market: Company Product Type Footprint
- 3.5.3 Beta-Nicotinamide Mononucleotide (NMN) Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size by Region
- 4.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2019-2030)
- 4.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2019-2030)
- 4.1.3 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Region (2019-2030)
- 4.2 North America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030)
- 4.3 Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030)
- 4.4 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030)
- 4.5 South America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030)
- 4.6 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2019-2030)
5 Market Segment by Type
- 5.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2030)
- 5.2 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Type (2019-2030)
- 5.3 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Type (2019-2030)
6 Market Segment by Application
- 6.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2030)
- 6.2 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Application (2019-2030)
- 6.3 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Application (2019-2030)
7 North America
- 7.1 North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2030)
- 7.2 North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2030)
- 7.3 North America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country
- 7.3.1 North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2019-2030)
- 7.3.2 North America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2019-2030)
- 7.3.3 United States Market Size and Forecast (2019-2030)
- 7.3.4 Canada Market Size and Forecast (2019-2030)
- 7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
- 8.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2030)
- 8.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2030)
- 8.3 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country
- 8.3.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2019-2030)
- 8.3.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2019-2030)
- 8.3.3 Germany Market Size and Forecast (2019-2030)
- 8.3.4 France Market Size and Forecast (2019-2030)
- 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
- 8.3.6 Russia Market Size and Forecast (2019-2030)
- 8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
- 9.1 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2030)
- 9.2 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2030)
- 9.3 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size by Region
- 9.3.1 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2019-2030)
- 9.3.2 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2019-2030)
- 9.3.3 China Market Size and Forecast (2019-2030)
- 9.3.4 Japan Market Size and Forecast (2019-2030)
- 9.3.5 South Korea Market Size and Forecast (2019-2030)
- 9.3.6 India Market Size and Forecast (2019-2030)
- 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
- 9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
- 10.1 South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2030)
- 10.2 South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2030)
- 10.3 South America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country
- 10.3.1 South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2019-2030)
- 10.3.2 South America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2019-2030)
- 10.3.3 Brazil Market Size and Forecast (2019-2030)
- 10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
- 11.1 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2019-2030)
- 11.2 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2019-2030)
- 11.3 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country
- 11.3.1 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2019-2030)
- 11.3.2 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2019-2030)
- 11.3.3 Turkey Market Size and Forecast (2019-2030)
- 11.3.4 Egypt Market Size and Forecast (2019-2030)
- 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
- 11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
- 12.1 Beta-Nicotinamide Mononucleotide (NMN) Market Drivers
- 12.2 Beta-Nicotinamide Mononucleotide (NMN) Market Restraints
- 12.3 Beta-Nicotinamide Mononucleotide (NMN) Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Beta-Nicotinamide Mononucleotide (NMN) and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Beta-Nicotinamide Mononucleotide (NMN)
- 13.3 Beta-Nicotinamide Mononucleotide (NMN) Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Beta-Nicotinamide Mononucleotide (NMN) Typical Distributors
- 14.3 Beta-Nicotinamide Mononucleotide (NMN) Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Beta-Nicotinamide Mononucleotide (NMN). Industry analysis & Market Report on Beta-Nicotinamide Mononucleotide (NMN) is a syndicated market report, published as Global Beta-Nicotinamide Mononucleotide (NMN) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Beta-Nicotinamide Mononucleotide (NMN) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
